Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.8M Buy
96,959
+8,410
+9% +$768K 0.09% 133
2026
Q1
$9.09M Sell
88,549
-2,774
-3% -$313K 0.1% 124
2025
Q4
$11.4M Buy
91,323
+4,824
+6% +$615K 0.15% 83
2025
Q3
$11.6M Sell
86,499
-23,225
-21% -$3.05M 0.25% 71
2025
Q2
$14.9M Buy
109,724
+18,281
+20% +$2.41M 0.35% 53
2025
Q1
$12.1M Buy
91,443
+17,494
+24% +$2.23M 0.32% 62
2024
Q4
$8.34M Sell
73,949
-8,456
-10% -$977K 0.22% 97
2024
Q3
$9.39M Buy
82,405
+9,426
+13% +$1.03M 0.25% 84
2024
Q2
$7.58M Sell
72,979
-5,894
-7% -$625K 0.22% 102
2024
Q1
$8.96M Buy
+78,873
New +$9.04M 0.28% 81

Other funds holding ABT

Allianz's ABT Position: Q2 2026 in Review

Allianz increased its Abbott (ABT) stake by 9.5% in Q2 2026, buying an estimated $768K and bringing the position to 96,959 shares worth $8.8M. The position accounts for 0.09% of the portfolio, ranked #133.

Allianz first reported a position in ABT in Q1 2024 and has held it in 10 quarters since. The position peaked at $14.9M in Q2 2025. 2,970 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Allianz held 96,959 shares of Abbott worth $8.8M as of Q2 2026.
  • Allianz bought 8,410 Abbott shares in Q2 2026, an estimated $768K.
  • Abbott made up 0.09% of Allianz's portfolio in Q2 2026, its #133 holding.
  • Allianz first reported a position in Abbott in Q1 2024 and has held it in 10 quarters since.
  • Allianz's Abbott position peaked at $14.9M in Q2 2025.
  • 2,970 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.